➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Medtronic
McKesson
Johnson and Johnson
Colorcon
McKinsey
Moodys

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

ALSUMA Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Alsuma, and when can generic versions of Alsuma launch?

Alsuma is a drug marketed by Meridian Medcl and is included in one NDA. There is one patent protecting this drug.

This drug has four patent family members in four countries.

The generic ingredient in ALSUMA is sumatriptan succinate. There are twenty-four drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the sumatriptan succinate profile page.

US ANDA Litigation and Generic Entry Outlook for Alsuma

A generic version of ALSUMA was approved as sumatriptan succinate by WEST-WARD PHARMS INT on February 6th, 2009.

  Start Trial

Summary for ALSUMA
International Patents:4
US Patents:1
Applicants:1
NDAs:1
Bulk Api Vendors: 95
Patent Applications: 1,370
Formulation / Manufacturing:see details
DailyMed Link:ALSUMA at DailyMed
Drug patent expirations by year for ALSUMA

US Patents and Regulatory Information for ALSUMA

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Meridian Medcl ALSUMA sumatriptan succinate INJECTABLE;SUBCUTANEOUS 022377-001 Jun 29, 2010 DISCN No No   Start Trial   Start Trial Y   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Merck
Moodys
McKesson
Express Scripts
Colorcon

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.